• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

作者信息

Brouwer Werner B F

机构信息

Erasmus School of Health Policy & Management, Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands.

Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Pharmacoeconomics. 2019 Apr;37(4):451-456. doi: 10.1007/s40273-018-0730-6.

DOI:10.1007/s40273-018-0730-6
PMID:30328563
Abstract
摘要

相似文献

1
The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.经济评估中纳入溢出效应：并非可有可无。
Pharmacoeconomics. 2019 Apr;37(4):451-456. doi: 10.1007/s40273-018-0730-6.
2
Analyzing the concept of spillover effects for expanded inclusion in health economics research.分析扩展健康经济学研究包容性的溢出效应概念。
J Comp Eff Res. 2020 Aug;9(11):755-766. doi: 10.2217/cer-2020-0051. Epub 2020 Jun 16.
3
Progress in measuring family spillover effects for economic evaluations.经济评估中衡量家庭溢出效应的进展。
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):195-8. doi: 10.1586/14737167.2015.997216. Epub 2014 Dec 29.
4
Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness.测量疾病家庭溢出效应的方法进展与新应用
Pharmacoeconomics. 2019 Apr;37(4):447-450. doi: 10.1007/s40273-019-00794-5.
5
Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time.量化经济评估中的家庭溢出效应：非正式护理时间的测量和估值。
Pharmacoeconomics. 2019 Apr;37(4):461-473. doi: 10.1007/s40273-019-00782-9.
6
[Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].[经济评估在医疗保健决策中越来越重要。在卫生经济学研究中，成本也必须与收益相平衡]
Lakartidningen. 2006;103(46):3624-7.
7
The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective.经济评估中溢出效应的纳入：公共卫生经济学视角
Pharmacoeconomics. 2019 Apr;37(4):621-623. doi: 10.1007/s40273-018-0748-9.
8
Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.拓展健康领域经济评估中成本与效益的范畴：几点警示
Pharmacoeconomics. 2019 Apr;37(4):457-460. doi: 10.1007/s40273-018-0729-z.
9
Discounting in economic evaluations: stepping forward towards optimal decision rules.经济评估中的贴现：朝着最优决策规则迈进。
Health Econ. 2007 Mar;16(3):307-17. doi: 10.1002/hec.1168.
10
An update on the health economics of asthma and allergy.哮喘与过敏症健康经济学的最新情况
Curr Opin Allergy Clin Immunol. 2002 Jun;2(3):195-200. doi: 10.1097/00130832-200206000-00007.

引用本文的文献

1
Does the Informal Carer Identification Method Matter? Evidence from Self-Declaration and Time Diary Approaches.非正式照料者识别方法重要吗？来自自我申报法和时间日志法的证据。
Pharmacoeconomics. 2025 May 16. doi: 10.1007/s40273-025-01506-y.
2
The Burden of Adult X-Linked Hypophosphatemia on Carers and Family Members: A Mixed-Methods Study.成人X连锁低磷血症对护理人员和家庭成员的负担：一项混合方法研究。
J Health Econ Outcomes Res. 2025 Apr 24;12(1):162-170. doi: 10.36469/001c.133860. eCollection 2025.
3
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment.

本文引用的文献

1
Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.拓展健康领域经济评估中成本与效益的范畴：几点警示
Pharmacoeconomics. 2019 Apr;37(4):457-460. doi: 10.1007/s40273-018-0729-z.
2
Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.衡量用于经济评估的健康溢出效应：以脑膜炎为例的案例研究
Health Econ. 2016 Dec;25(12):1529-1544. doi: 10.1002/hec.3259. Epub 2015 Oct 14.
3
A Framework for Including Family Health Spillovers in Economic Evaluation.将家庭健康溢出效应纳入经济评估的框架。
值得思考的问题：在卫生技术评估中纳入照护者观点的更明确指南。
Int J Technol Assess Health Care. 2024 Dec 12;40(1):e77. doi: 10.1017/S0266462324004690.
4
Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment.制定利益相关者知情的建议，以纳入健康技术评估中的家庭溢出效应。
J Manag Care Spec Pharm. 2024 Sep;30(9):1013-1024. doi: 10.18553/jmcp.2024.30.9.1013.
5
Social costs associated with fibromyalgia in Spain.西班牙纤维肌痛相关的社会成本。
Health Econ Rev. 2024 Jul 13;14(1):51. doi: 10.1186/s13561-024-00527-1.
6
A Systematic Review of Methods and Practice for Integrating Maternal, Fetal, and Child Health Outcomes, and Family Spillover Effects into Cost-Utility Analyses.系统评价将母婴、胎儿和儿童健康结局以及家庭溢出效应纳入成本效用分析的方法和实践。
Pharmacoeconomics. 2024 Aug;42(8):843-863. doi: 10.1007/s40273-024-01397-5. Epub 2024 May 31.
7
The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events.EQ-HWB-S作为经历不良事件家庭中照顾者生活质量衡量指标的表现。
Eur J Health Econ. 2025 Feb;26(1):7-21. doi: 10.1007/s10198-024-01688-w. Epub 2024 Apr 5.
8
Economic Evaluations of Treatments for Duchenne Muscular Dystrophy: The Caregiver QALY Trap.杜氏肌营养不良症治疗的经济评估：照顾者质量调整生命年陷阱
Pharmacoeconomics. 2024 May;42(5):475-478. doi: 10.1007/s40273-024-01367-x. Epub 2024 Mar 5.
9
Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.将家庭报告结局测量量表（FROM-16）评分映射至 EQ-5D：计算效用值的算法。
Qual Life Res. 2024 Apr;33(4):1107-1119. doi: 10.1007/s11136-023-03590-z. Epub 2024 Feb 25.
10
On spillovers in economic evaluations: definition, mapping review and research agenda.关于经济评估中的溢出效应：定义、映射综述和研究议程。
Eur J Health Econ. 2024 Sep;25(7):1239-1260. doi: 10.1007/s10198-023-01658-8. Epub 2024 Jan 23.
Med Decis Making. 2016 Feb;36(2):176-86. doi: 10.1177/0272989X15605094. Epub 2015 Sep 16.
4
Progress in measuring family spillover effects for economic evaluations.经济评估中衡量家庭溢出效应的进展。
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):195-8. doi: 10.1586/14737167.2015.997216. Epub 2014 Dec 29.
5
Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies.在经济评估中纳入非正式护理重要吗？对成本效益研究中非正式护理的纳入情况及其影响的系统评价。
Pharmacoeconomics. 2015 Feb;33(2):123-35. doi: 10.1007/s40273-014-0218-y.
6
Informal care and caregiver's health.非正式护理与照料者的健康。
Health Econ. 2015 Feb;24(2):224-37. doi: 10.1002/hec.3012. Epub 2014 Apr 17.
7
How to include informal care in economic evaluations.如何将非正规护理纳入经济评价。
Pharmacoeconomics. 2013 Dec;31(12):1105-19. doi: 10.1007/s40273-013-0104-z.
8
Measuring the impact of caregiving on informal carers: a construct validation study of the CarerQol instrument.测量照料对非正式照护者的影响：照料者生活质量量表的构建效度研究。
Health Qual Life Outcomes. 2013 Oct 21;11:173. doi: 10.1186/1477-7525-11-173.
9
Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.药物经济学指南应规定纳入间接医疗成本！对格里马等人的回应
Pharmacoeconomics. 2013 May;31(5):369-73; discussion 375-6. doi: 10.1007/s40273-013-0042-9.
10
Disutility of illness for caregivers and families: a systematic review of the literature.照顾者和家属的疾病不舒适：文献系统综述。
Pharmacoeconomics. 2013 Jun;31(6):489-500. doi: 10.1007/s40273-013-0040-y.